+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Regression and prevention of left ventricular hypertrophy are possible in hypertensive heart transplant recipients



Regression and prevention of left ventricular hypertrophy are possible in hypertensive heart transplant recipients



Journal of the American College of Cardiology 15(2 SUPPL A): 223A




(PDF emailed within 0-6 h: $19.90)

Accession: 033141154

Download citation: RISBibTeXText

DOI: 10.1016/0735-1097(90)92608-5


Related references

Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide, and verapamil. Circulation 84(2): 583-593, 1991

Ultrasonic regression of left ventricular hypertrophy is associated with a decrease in morphometrically determined myocyte size in hypertensive heart transplant recipients. Circulation 88(4 PART 2): I615, 1993

Left ventricular hypertrophy in hypertensive heart transplant recipients. Hypertension (Dallas) 17(3): 411, 1991

Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proceedings of the National Academy of Sciences of the United States of America 79(10): 3310-3314, 1982

Regression of left ventricular hypertrophy by AT1 receptor blockade in renal transplant recipients. American Journal of Hypertension 13(12): 1295-1300, December, 2000

Ultrasonic regression of LV hypertrophy is associated with a decrease in myocyte size in hypertensive heart transplant recipients. European Heart Journal 14(ABSTR SUPPL ): 82, 1993

Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects. American Journal of Hypertension 19(5): 493-499, 2006

Comparison of irbesartan vs felodipine in the regression after 1 year of left ventricular hypertrophy in hypertensive patients (the SILVER trial). Study of Irbesartan in Left VEntricular hypertrophy Regression. Journal of Human Hypertension 12(7): 479-483, 1998

Regression of left ventricular hypertrophy in hypertensive heart disease. Herz 28(8): 764-778, 2003

Regression of left ventricular hypertrophy after arteriovenous fistula closure in renal transplant recipients: a long-term follow-up. American Journal of Transplantation 4(12): 2038-2044, 2004

Regression of left ventricular hypertrophy in kidney transplant recipients: the potential role for inhibition of mammalian target of rapamycin. Transplantation Proceedings 42(9 Suppl): S41-S43, 2011

In hypertensive heart transplant recipients ultrasonic regression of LV hypertrophy during antihypertensive treatment is associated with a decrease in morphometrically determined myocyte size. Journal of Heart & Lung Transplantation 13(1 PART 2): S77, 1994

Regression of left heart hypertrophy with clonidine. Prevention of hypertensive heart disease. Fortschritte der Medizin 104(26): 522-524, 1986

Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients. Annals of Internal Medicine 147(5): 311-319, 2007